Treatment of irritable bowel syndrome

British Medical Journal

Volumn 330, Issue 7489, 2005, Pages 429-430

  Farthing, Michael J G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; CILANSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; TEGASEROD;

ANALGESIA; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; EDITORIAL; HUMAN; HYPNOSIS; IRRITABLE COLON; ISCHEMIC COLITIS; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; RECEPTOR BLOCKING; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 14644392797     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7489.429     Document Type: Editorial

References (12)

1. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:2032-48.
2. Farthing MJG. Treatment options in irritable bowel syndrome. Best Pract Res Clin Gastroenterol 2004;18:773-86.
3. Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhoea-predominant irritable bowel syndrome. Arch Intern Med 2001;161:1733-40.
4. Higgins PDR, Davis KJ, Laine L. Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther 2004;19:729-38.
5. Blinker A, Avigan M. Epidemiology of ischaemic colitis. Aliment Pharmacol Ther 2004;20:697-9.
6. Corazziari E, Bytzer P, Delvaux M, Holtmann G, Malagelada JR, Morris J, et al. Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:569-80.
7. Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2004;(1):CD003960.
8. Brinker AD, Mackey AC, Prizont R. Tegaserod and ischemic colitis. N Engl J Med 2004;351:1361-2.
9. Joelsson BE, Shetzline MA, Cunningham S. Tegaserod and ischemic colitis. N Engl J Med 2004;351:1363.
10. Saito YA, Prather CM, Van Dyke CT, Fett S, Zinsmeister AR, Locke GR. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hep 2004;2:576-84.
11. Heitkemper MM, Jarrett ME, Levy RL, Cain KC, Burr RL, Feld A, et al. Self-management for women with irritable bowel syndrome. Clin Gastroenterol Hep 2004;2:585-96.
12. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, et al. Cognitive-behavioral therapy versus education and desimipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2004;125:249-53.